Postpartum depression pill gets approval in a 1st for Canada – National
Health Canada has approved the first drug designed to treat postpartum depression. Zuranolone, sold under the brand name Zurzuvae, is...
Health Canada has approved the first drug designed to treat postpartum depression. Zuranolone, sold under the brand name Zurzuvae, is...
Postpartum Product MarketMarket OverviewThe Postpartum Product Market is experiencing significant growth worldwide as maternal health awareness rises and more new...
Chen Q, Li W, Xiong J, Zheng X. Prevalence and risk factors associated with postpartum depression during the COVID-19 pandemic:...
Carea, a pregnancy and postnatal wellbeing app that prioritises women’s health, has launched the Postpartum Mum Tracker to support the...
Hoyert DL, Miniño AM. Maternal mortality in the United States: changes in coding, publication, and data release, 2018.Hoyert DL. Maternal...
Each year, VA Greater Los Angeles Healthcare System (VAGLAHS) hosts a Baby Shower to celebrate expecting and postpartum Veterans. Far...
American College of Obstetricians and Gynecologists. Physical activity and exercise during pregnancy and the postpartum period: ACOG committee opinion, number...
Depression was predicted to rank as the second most prevalent cause of disability globally in 2023 . A kind of...
An expert in reproductive psychiatry at the University of Virginia School of Medicine is among an international panel of leading...